Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Kidney Disease Market Revenue Growth Supported By A CAGR Of 159.57% Through 2030

The global kidney disease market experienced significant expansion recently and is projected to continue this upward trajectory, expanding from $114.39 billion in 2025 to $121.98 billion by 2026, reflecting a compound annual growth rate of 6.6%. This historical growth was propelled by factors including the mounting number of individuals suffering from chronic kidney disease, a higher occurrence of diabetes and hypertension, the widespread adoption of dialysis and pharmaceutical treatments, an increase in inpatient renal services, and broader accessibility to diagnostic evaluations.

The market for kidney disease is poised for significant expansion, projected to reach a value of $159.58 billion by the year 2030, reflecting a compound annual growth rate of 6.9%. This anticipated growth is propelled by several key factors: an increasing elderly demographic with a heightened susceptibility to kidney issues, a growing preference for at-home dialysis solutions, augmented investments in research dedicated to kidney ailments, a heightened emphasis on proactive screening initiatives, and broadened accessibility to kidney care services in developing economies. During this forecast period, dominant trends are expected to include a greater emphasis on identifying diseases early and managing them effectively, a wider embrace of dialysis and other renal replacement treatments, a surging demand for tailored treatment plans for individuals with kidney disease, the proliferation of integrated care approaches for patients with renal conditions, and enhanced public understanding coupled with preventative health efforts.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

Kidney Disease Market Growth Drivers: What Factors Are Accelerating Expansion?

The expanding prevalence of kidney ailments is anticipated to be a primary catalyst for the advancement of the kidney disease market. Kidney disorders encompass a range of conditions that impair the functionality and integrity of the renal organs. Pharmaceutical interventions for kidney disorders are designed to decrease blood pressure and mitigate protein effusion, thereby decelerating the deterioration of kidney damage, alleviating associated symptoms, and circumventing further complications. Illustratively, within the United Kingdom, Kidney Research UK reported in June 2023 that an estimated 7.19 million individuals suffered from chronic kidney disease in 2023, a figure constituting over 10% of the nation’s populace, with projections indicating a rise to 7.61 million by 2033. Consequently, the escalating rate of kidney disease diagnoses is fueling market expansion.

Kidney Disease Market Segment Breakdown: Which Categories Generate The Most Revenue?

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Kidney Disease Market Trends: What Is Shaping Future Industry Growth?

Leading players within the kidney disease sector are prioritizing the integration of technologically advanced solutions, specifically highlighting compact hemodialysis units employing cartridges. These systems are designed to elevate treatment adaptability, user convenience, and operational effectiveness. Such cartridge-based hemodialysis machinery represents portable dialysis apparatuses that substitute conventional fluid bags with disposable dialysate cartridges. This substitution unlocks functionalities like automatic dialysate formulation, streamlined setup procedures, and enhanced suitability for at-home treatment regimens. As an illustrative example, Quanta Dialysis Technologies, a firm situated in the UK specializing in dialysis innovation, secured FDA approval in November 2024 for its Quanta Dialysis System. This system, a cartridge-driven hemodialysis device engineered for both home use and adaptable deployment in various care environments, boasts a small physical profile, generates dialysate as needed, and features an easy-to-use touchscreen. Ultimately, the Quanta Dialysis System contributes to greater patient independence, simplifies the administration of treatments, and boosts overall efficiency in dialysis operations across different care scenarios, with the market value associated with this driver standing at USD 3.7 billion for 2024.

Kidney Disease Market Key Players And Strategic Industry Positioning

Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited

Access The Complete Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Kidney Disease Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model